Cargando…

First person – Jianhao Zeng

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Jianhao Zeng is first author on ‘ A genetic mosaic mouse model illuminates the pre-malignant progression...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668024/
http://dx.doi.org/10.1242/dmm.050510
_version_ 1785149073447190528
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Jianhao Zeng is first author on ‘ A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer’, published in DMM. Jianhao conducted the research described in this article while a PhD student in Hui Zong's lab at University of Virginia Health System, Charlottesville, VA, USA. He is now a postdoc in the lab of Hamideh Parhiz at University of Pennsylvania, Philadelphia, PA, USA, investigating mRNA-based in vivo cellular reprogramming for cancer prevention and treatment.
format Online
Article
Text
id pubmed-10668024
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-106680242023-11-13 First person – Jianhao Zeng Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Jianhao Zeng is first author on ‘ A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer’, published in DMM. Jianhao conducted the research described in this article while a PhD student in Hui Zong's lab at University of Virginia Health System, Charlottesville, VA, USA. He is now a postdoc in the lab of Hamideh Parhiz at University of Pennsylvania, Philadelphia, PA, USA, investigating mRNA-based in vivo cellular reprogramming for cancer prevention and treatment. The Company of Biologists Ltd 2023-11-13 /pmc/articles/PMC10668024/ http://dx.doi.org/10.1242/dmm.050510 Text en © 2023. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Jianhao Zeng
title First person – Jianhao Zeng
title_full First person – Jianhao Zeng
title_fullStr First person – Jianhao Zeng
title_full_unstemmed First person – Jianhao Zeng
title_short First person – Jianhao Zeng
title_sort first person – jianhao zeng
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668024/
http://dx.doi.org/10.1242/dmm.050510